Sep
14
2021

AcouSort AB genomför fullt säkerställd företrädesemission av units om cirka 40 MSEK

Regulatory

Styrelsen i AcouSort AB (publ) (“AcouSort” eller “Bolaget”) har idag, med stöd av årsstämmans bemyndigande, beslutat att genomföra en nyemission av högst 1 886 040 units bestående av aktier och

Read More
Aug
25
2021

AcouSort Interim Report Q2 2021

Regulatory

Today, August 25 2021, AcouSort is releasing its InterimReport for Q2, 2021. The report is in both Swedish and English. Read the full report here.

Read More
Aug
24
2021

Martin Olin becomes CEO of Norwegian BerGenBio – continues as chairman for AcouSort

AcouSort’s Chairman of the Board, Martin Olin, has been appointed CEO of the Norwegian biotechnology company BerGenBio ASA. Martin Olin will take up his new position on September 8 this

Read More
Jul
6
2021

AcouSort sells AcouWash system to Japanese distributor

AcouSort has sold an AcouWash system to its Japanese distributor Physio-Tech. Physio-Tech has over the last year worked intensively with introducing AcouSort’s bench-top systems to the Japanese market. Since the

Read More
Jun
29
2021

First collaboration phase with Belgian diagnostics company finalized

AcouSort has finalized the first phase of the previously announced collaboration project with a Belgian diagnostics company that develops innovative products for point-of-care testing. AcouSort has over the past months

Read More
Jun
16
2021

AcouSort reaches milestone for AcouPlasma Optical

The development process of AcouPlasma Optical has now reached an important milestone. The project has reached “Design freeze”, meaning that the final product design is finished. Read full pressrelease in

Read More
May
26
2021

AcouSort Interim Report Q1 2021

Today, May 26 2021, AcouSort is releasing its InterimReport for Q1, 2021. The report is in both Swedish and English. Read the full report here

Read More
May
17
2021

Promising results in AcouSort’s latest feasibility study with Instrumentation Laboratory

AcouSort has finalized the recent feasibility project with Instrumentation Laboratory (IL) concerning generation of blood plasma aiming to expand the use of AcouSort’s technology in additional IL product lines. The

Read More
May
3
2021

AcouSort and Pharmacolog sign letter of intent to investigate integration of AcouSort’s blood separation technology

AcouSort AB and Uppsala-based Pharmacolog AB has signed a letter of intent concerning a long-term collaboration focused on investigating the potential of integrating AcouSort’s technology in Pharmacolog’s products. The aim

Read More
Apr
28
2021

Communiqué from the Annual General Meeting of AcouSort AB (publ)

Regulatory

Today, April 28, 2021, the Annual General Meeting of AcouSort AB (publ) was held. Below is a summary of the decisions made. All decisions were made by the required majority.

Read More